Shield Therapeutics (STX) Share Forecast, Price & News

Shield Therapeutics (LON:STX) Frequently Asked Questions

Is Shield Therapeutics a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shield Therapeutics in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Shield Therapeutics stock.
View analyst ratings for Shield Therapeutics or view top-rated stocks.

Who are Shield Therapeutics' key executives?

Shield Therapeutics' management team includes the following people:

• Mr. Christian Schweiger M.D., Ph.D., Co-Founder & Non Exec. Director (Age 55, Pay $20k)
• Mr. Gregory P. Madison, CEO & Director (Age 54)
• Mr. Hans-Peter Rudolf, Chief Financial Officer
• Ms. Lucy Huntington-Bailey, Gen. Counsel & Company Sec.
• Ms. Suzanne Wood, Group HR Director
• Ms. Carol Akinola, Head of Pharmacovigilance & Medical Information
• Dr. José A. Menoyo M.D., Chief Medical Officer

Who are some of Shield Therapeutics' key competitors?

Some companies that are related to Shield Therapeutics include BioSyent (RX), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), Science in Sport (SIS), WeedMD (WMD), Cipher Pharmaceuticals (CPH), Venture Life Group (VLG), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), Indiva (NDVA), Acerus Pharmaceuticals (ASP), InMed Pharmaceuticals (IN), Diurnal Group (DNL), Flowr (FLWR) and Evgen Pharma (EVG).
View all of STX's competitors.

What other stocks do shareholders of Shield Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shield Therapeutics investors own include AcelRx Pharmaceuticals (ACRX), Rockwell Medical (RMTI), Cara Therapeutics (CARA), Caladrius Biosciences (CLBS), Cellectis (CLLS), Geron (GERN), Concepta PLC (CPT.L) (CPT), Fresnillo (FRES), OptiBiotix Health (OPTI) and SkinBioTherapeutics (SBTX).

What is Shield Therapeutics' stock symbol?

Shield Therapeutics trades on the London Stock Exchange (LON) under the ticker symbol "STX."

How do I buy shares of Shield Therapeutics?

Shares of STX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Shield Therapeutics' stock price today?

One share of STX stock can currently be purchased for approximately GBX 14.75.

How much money does Shield Therapeutics make?

Shield Therapeutics has a market capitalization of £31.84 million and generates £1.95 million in revenue each year.

How many employees does Shield Therapeutics have?

Shield Therapeutics employs 15 workers across the globe.

What is Shield Therapeutics' official website?

The official website for Shield Therapeutics is www.shieldtherapeutics.com.

How can I contact Shield Therapeutics?

Shield Therapeutics' mailing address is 3rd Fl Baltic Business Quarters, Abbott's Hill, GATESHEAD, NE8 3D, United Kingdom. The company can be reached via phone at +44-191-5118500.